Christine M. Klaskin - 17 Jun 2025 Form 4 Insider Report for AGENUS INC (AGEN)

Reporting relationship: PFO & PAO
Issuer ticker: AGEN
Reported as of: 17 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Jun 2025, 16:05:05 UTC
Prior SEC filing: 18 Nov 2024
Next SEC filing: 30 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/Christine Klaskin

Key filing fact

Christine M. Klaskin filed Form 4 for AGENUS INC (AGEN) on 20 Jun 2025.

Key facts

This page summarizes Christine M. Klaskin's Form 4 filing for AGENUS INC (AGEN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 20 Jun 2025, 16:05.

Change

Previous filing in this sequence was filed on 18 Nov 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001288123 Primary reporting owner

KLASKIN CHRISTINE M

Relationship: PFO & PAO
Address: C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON
Signature: /s/Christine Klaskin
Signature date: 20 Jun 2024

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGEN transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +7,250
Change %
Price: $0.000000
Shares after: 7,250
Date: 17 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,250
Exercise price: $3.02
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options were granted on May 28, 2025 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 17, 2025. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on May 28, 2026 and the balance vesting in equal quarterly installments thereafter.